Stocktoria
SOLESENCE, INC. SLSN
SOLESENCE, INC. (SLSN) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $62.1M at a 2.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.14 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.297 |
| Retained earnings / assets | -1.971 |
| EBIT / assets | 0.031 |
| Equity / liabilities | 0.544 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SLSN | SOLESENCE, INC. | 3/9 | -3.7 | 32.6 | +18.6% |
| AXIL | Axil Brands, Inc. | 6/9 | 7.41 | 51.2 | -4.5% |
| UG | UNITED GUARDIAN INC | 4/9 | 15.38 | 15.7 | -13.4% |
| PTNM | Pitanium Ltd | 2/9 | 2.33 | — | -88.7% |
| BNKK | BONK, INC. | 4/9 | — | — | — |
| SHFH | Scientist Home Future Health Ltd | — | -3.67 | — | — |
| CABR | Caring Brands, Inc. | 2/9 | -11.76 | — | — |
About SOLESENCE, INC.
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
FAQ
Is SLSN financially healthy?
SOLESENCE, INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does SLSN pay a dividend?
No, SOLESENCE, INC. does not currently pay a dividend.
How profitable is SLSN?
In FY2025, SOLESENCE, INC. had a net margin of 2.9% and a return on equity of 10.2%.
Is SLSN overvalued or undervalued?
SOLESENCE, INC. trades at about 52.5× trailing earnings — below its 10-year norm (10-year range 30.7×–67.5×, median 59.0×). Stocktoria reports the data, not buy/sell advice.
Is SLSN a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on SOLESENCE, INC.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone, a P/E of about 32.6×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.